Journal Information
Editorial
Opinion article
Review article
Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab
G. Guhl, B. Díaz-Ley, J. Fernández-Herrera
Actas Dermosifiliogr. 2008;99:5-33
Full text access
Practical dermatology
Original articles
Case reports
Cases for diagnosis
Olavide museum
Arts corner
Letters to the editor